Excited to share our preprint led by Carlos Voogdt et al
We developed new genetic tools & genome-wide libraries for species of the Bacteroidales order; constructed saturated barcoded transposon libraries in key representatives of three genera.
www.biorxiv.org/content/10.1...
Congrats! Nice to see it published!
How the @embo.org postdoctoral fellowship helped me in developing my academic career... happy to see my profile featured on the EMBO website!
www.embo.org/people/from-...
I was waiting two years to see this out!! The genomic location of bacterial genes is not random!!! Congratulation on the authors (Martin Lercher and Team!). www.science.org/doi/10.1126/...
I attended the course in 2022, as it’s held every three years. It combines diverse, exciting science with close-knit socializing on a beautiful Greek island.
Highly recommended for PhD students at any stage!
@typaslab.bsky.social
Resistance to one antibiotic can make bacteria resistant or sensitive to another antibiotic, opening paths for combinatorial treatments. A study in Nature Microbiology presents an approach to systematically discover and understand such antibiotic relationships. https://go.nature.com/49of3Mk 🧪
(1/3) Antibiotic resistance is costing human lives. 🦠
A study from EMBL's Typas group proposed a framework to identify antibiotic pairs that make bacteria resistant to one antibiotic but sensitive to other – this can help design new treatments and delay resistance. 🧬🧪
www.nature.com/articles/s41...
My PhD work is now published in Nature Microbiology! Please, have a look!
We present a framework for faster, cheaper and systematic antibiotic XR & CS discovery with chemical genetics, mechanism deconvolution, and reduction of resistance evolution, paving the way for rationally designed treatments. Thanks to @elisca.bsky.social @typaslab.bsky.social and everyone involved!
Antibiotic (abx) resistance is outpacing new abx discovery. This is worsened by cross-resistance (XR) between abx. However, resistance can also lead to collateral sensitivity (CS) to other abx, providing new treatment opportunities. In our new preprint www.biorxiv.org/content/10.1...